Chesterfield, MO, United States of America

Bradley T Keller

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 190(Granted Patents)


Company Filing History:


Years Active: 2001-2022

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator Spotlight - Bradley T Keller

Introduction:

Bradley T Keller, a prolific inventor hailing from Chesterfield, MO (US), has made significant contributions to the field of biotechnology with his groundbreaking patents. With a total of 11 patents to his name, Keller's innovative work has focused on developing compounds and methods for treating oxalate-related diseases and nucleic acids encoding antibodies to CCR2.

Latest Patents:

One of Keller's latest patents involves the development of compounds and compositions for modulating glycolate oxidase, a crucial step in treating oxalate-related diseases such as hyperoxaluria. Additionally, Keller's work includes the creation of antibodies that specifically bind to CCR2, with the potential to inhibit this critical target. These patents demonstrate Keller's commitment to advancing medical treatments through innovative solutions.

Career Highlights:

Throughout his career, Bradley T Keller has held key positions at renowned companies such as G.D. Searle & Company and Pfizer Corporation. His tenure at these esteemed organizations has provided Keller with the platform to translate his scientific expertise into tangible inventions that have the potential to revolutionize the healthcare industry.

Collaborations:

Keller has had the privilege of collaborating with esteemed professionals in the field, including coworkers Kevin C Glenn and Robert E Manning. Through these collaborations, Keller has been able to leverage collective knowledge and skills to bring his inventive concepts to fruition, showcasing his ability to work effectively in a team setting.

Conclusion:

In conclusion, Bradley T Keller stands out as a visionary inventor whose work has the power to transform the landscape of biotechnology. With a focus on developing treatments for oxalate-related diseases and innovative antibody technologies, Keller's patents underscore his dedication to pioneering advancements that have the potential to improve the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…